Description
Inclusion Criteria:
- * Pathological proven diagnosis of prostatic adenocarcinoma
- * History and physical exam to establish clinical staging
- * Clinical stage T1-T2c (AJCC 7th edition)
- * Prostate specific antigen (PSA) \< 20 ng/mL
- * Gleason Score ≤ 7
- * Eastern Cooperative Oncology Group (ECOG) Performance status 0-1
- * Patients must be 18 years of age or older
- * Willingness and ability to complete the International Prostate Symptom Score (IPSS) survey and Expanded Prostate Cancer Index Composite (EPIC) questionnaire
Exclusion Criteria:
- * Prior radiotherapy to the pelvic area
- * Prior prostate cancer therapy: cryotherapy or hyperthermia
- * Prior systemic therapy (chemotherapy) for prostate cancer
- * Regional lymph nodes (common iliac, external iliac, internal iliac, presacral) are a target of treatment
- * Active diverticulitis, ulcerative colitis, or Crohn's disease
Ages Eligible for Study:
18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: MALE
Accepts Healthy Volunteers:
No